Endothelin-1 induction of cyclooxygenase.2 expression in rat mesangial cells. Prostaglandin E2 (POE2) may be an important negative feedback modulator of endothelin-1 (ET-1)-stimulated mesangial cell proliferation and contraction. Recent studies suggest that ET-1 may induce prolonged mesangial cell POE2 production, however the mechanism of this effect is unknown. The current study was undertaken, therefore, to examine the long-term effect of ET-1 on mesangial cell POE2 synthesis. ET-1 markedly increased POE2 release by rat mesangial cells for at least six hours.
to contract, proliferate, and produce platelet-derived growth factor, collagenase and fibronectin [4] [5] [6] [7] [8] . These observations have led to the hypothesis that ET-1 plays an important role in glomerular pathophysiology as well as normal physiology. For example, ET-1 has been implicated in the reduced glomerular filtration rate that occurs in the settings of acute ischemic renal failure and acute cyclosporine nephrotoxicity [9, 10] . In addition, since mesangial cell proliferation is a common component of glomerular inflammation and since glomerular ET-1 levels are increased in experimental glomerulonephritis, ET-1 has been proposed to be of pathogenic importance in proliferative glomerular diseases [11] .
The cellular events accompanying ET-1 receptor activation in mesangial cells have been examined in some detail. ET-1 binding to mesangial cells activates numerous signal transduction systems [4, 7, 12, 13] . Of these second messengers, the ability of ET-1 to increase arachidonate metabolites may be of particular importance. While it remains controversial as to the nature of all eicosanoids produced, it appears that ET-1 stimulates mesangial cells to produce relatively large amounts of prostaglandin E2 (PGE2) [13, 14] . Several studies have shown that vasorelaxant prostanoids serve as negative feedback modulators of ET-1induced cell contraction. For example, ET-1-induced mesangial cell contraction is attenuated by POE2 [14] , while cyclooxygenase inhibition increases the severity of renal vasoconstriction following ET-1 administration [15] . ET-1 stimulation of mesangial cell POE2 production might also modulate mitogenesis and extracellular matrix production since PGE2 inhibits collagen production and proliferation by mesangial cells [16] .
Because the physiological effects of ET-1 can last for several hours, it is of particular interest that the peptide has been reported to cause sustained elevations in mesangial cell PGE2 production [13] . The mechanism(s) responsible for such sustained induction of PGE2 synthesis are uncertain; however, recent studies raise the possibility that induction of a recently described cyclooxygenase may be involved, cyclooxygenase-2 (COX-2). Cyclooxygenase-1 (COX-1) is constitutively expressed by many cell types. Its synthesis can be induced by several cytokines, albeit often to a modest degree [17] . In contrast, COX-2 belongs to the family of early response genes and is primarily inducible [18, 19] . CA, USA); RNasin was from Promega (Madison, WI, USA); Moloney Murine Leukemia Virus reverse transcriptase and Taq polymerase was from Gibco BRL (Grand Island, NY, USA); random hexamers were from Boehringer-Mannheim (Indianapolis, IN, USA); dNTPs were from LKB-Pharmacia (Piscataway, NJ, USA); and 32P-dCTP was from Amersham (Arlington Heights, IL, USA). Oligonucleotide primers for rat COX-1, COX-2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were synthesized by Dr. Robert Schackmann at the University of Utah. All other chemicals and reagents used were from Sigma Chemical Co. (St. Louis, MO, USA) unless otherwise stated.
Cell culture
Mesangial cells were isolated from rats as previously described [20] . Briefly, glomeruli were obtained using 60, 100, and 200 mesh sieves, incubated in 750 U/ml collagenase (type IV) and 0.01% deoxyribonuclease (type I, Sigma) for 30 minutes at 37°C. Digested glomeruli were washed twice and cultured in RPMI-1640 containing 20% bovine calf serum (BCS) and insulin (0.5 U/ml) at 37°C in a 5% CO2 incubator. Cultures were studied at confluence in 6-or 24-well plates (Costar, Pleasonton, CA, USA) between passages 5 and 10; 99% of cells were positive by immunofluorescence for smooth muscle myosin.
PGE2 release studies
Mesangial cells were grown to confluence in the presence of RPMI + insulin + 20% BCS and studied either immediately (cycling cells) or after three days exposure to RPM! without insulin or BCS (growth-arrested cells). The ability of this latter procedure to render mesangial cells G0 has been well documented [211. All studies were performed at 37°C in a 5% CO2 incubator.
For time course and dose-response studies, cycling and growtharrested cells were incubated in RPMI in the presence and absence of ET-1 (10 M to 100 nM)for 15 minutes to six hours. For ET receptor subtype studies, growth-arrested mesangial cells were incubated in RPMI with and without 10 nrvi ET-1 in the presence For studies on dexamethasone regulation of ET-1 action, growth-arrested mesangial cells were pre-incubated for two hours in either RPM! alone or RPMI containing 2 LM dexamethasone. Subsequently, the media was changed to RPMI with and without 2 M dexamethasone and in the presence or absence of 10 flM ET-1 and incubated for 15 minutes to six hours. For studies on cycloheximide or actinomycin-D regulation of ET-1 action, growth-arrested mesangial cells were pre-incubated for 15 minutes in either RPMI alone or RPM! containing 10 jtg/ml cycloheximide or 1 jtg/ml actinomycin-D. Subsequently, the media was changed to RPMI with and without 10 g/ml cycloheximide or 1 g/ml actinomycin-D and in the presence or absence of 10 nvi ET-1 for 15 minutes to six hours. Only growth-arrested cells were used for dexamethasone, cycloheximide and actinomycin-D studies; all of these agents alter the effect of serum on PGE2 synthesis and cyclooxygenase mRNA in mesangial cells [71, thereby potentially confusing interpretation of how ET-1 actions are influenced. At the end of the incubations, a 50 j.d aliquot was removed from the cell supernatant and PGE2 assayed by a commercially available radioimmunoassay (Amersham). Total cell protein was measured in each well by mixing an aliquot of solubilized mesangial cells in 0.1 N NaOH with Bradford reagent and absorbance at 650 nm determined [23] . All results are expressed as pg PGE2/ig total cell protein.
Determination of cyclooxygenase activity
Growth-arrested cells were incubated with RPMI alone or containing 10 nM ET-1 for up to 6 hours. The cells were then rinsed and 10 tM arachidonic acid in RPMI added for 15 minutes. In preliminary studies using 1 to 100 .tM arachidonic acid, it was determined that 10 tM arachidonic acid caused maximal PGE2 production. At the end of the 15 minute incubation with saturating concentrations of arachidonic acid, media PGE2 content and total cell protein were determined as described above.
Determination of relative levels of COX-1 and COX-2 protein
Growth-arrested mesangial cells were pre-incubated for two hours with RPMI alone or containing 2 M dexamethasone. ET-1 (10 nM) was then added to half the wells pre-incubated with RPMI alone or containing dexamethasone for up to six hours. The cells were then lysed in ice-cold buffer (20 mM Tris-HCI (pH 7.5), 16 mM CHAPS, 1 mrvi EDTA, 0.5 mrvt dithiothreitol, 1 mM benzamidine hydrochloride, 1 jtg/ml leupeptin, 10 g/ml soybean trypsin inhibitor) for 30 minutes. The samples were centrifuged for five minutes at 10,000 X g at 4°C and the protein concentration in the supernatant determined using a microbicinchoninic acid assay (Pierce). An aliquot containing the same amount of protein was taken from the supernatants of each sample and mixed with loading buffer (125 m'vi Tris-HC1 pH 6.8, 1% SDS, 5% glycerol, 10% 2-mercaptoethanol, and bromophenol blue) and heated at 85°C for 10 minutes before loading on an acrylamide gel (10% and 3% loading and stacking, respectively). Samples were electrophoresed and transferred onto Hybond-ECL nitrocellulose membranes (Amersham) using a Hoefer Scientific Instruments TE 52X Transphor Electrophoresis Unit. To minimize non-specific binding, blots were blocked overnight at 4°C in TBST (50 mrvi Tris-HCI, pH 7.5, 250 mrvi NaCl, 0.1% Tween 20) plus 5% nonfat dry milk, and 1% normal serum of the species that the secondary antibody was raised in. To detect COX-2, a polyclonal antibody raised against a synthetic polypeptide of the unique 18 amino acid sequence near the C-terminus of the human form of the enzyme [241 was diluted 250:1 in blocking buffer and incubated with the membrane for four hours at room temperature. The membrane was washed four times in blocking buffer, and twice in TBST alone. Donkey anti-rabbit IgG linked to horseradish peroxidase was diluted 1000:1 in TBST and incubated with the membrane for one hour at room temperature. The membrane was washed extensively in TBST before detecting the bands by chemiluminesence following the manufacturer's directions (Amersham). The membrane was then stripped by incubating in 62.5 mM Tris-HC1 (pH 6.7), 100 mrvi 2-mercaptoethanol, and 2% SDS at 50°C for one hour. After washing in TBST, the membrane was blocked as before. To detect COX-1, a monoclonal antibody prepared against ram seminal vesicle COX-1 [241 was diluted 10,000:1 in blocking buffer and incubated for one hour at room temperature. The remainder of the detection process was identical to that for COX-2 with the exception of using a horseradish peroxidase linked sheep anti-mouse secondary antibody.
Determination of relative amounts of COX-1, COX-2 and GAPDH mRNA Confluent cultures of growth-arrested mesangial cells were exposed to RPM! alone, 10 nM ET-1, 2 LM dexamethasone, or 10 g/ml cycloheximide for 15 minutes, 1, 2 or six hours in a manner identical to that described under measurement of PGE2 37°C. The sample was then heated at 94°C for 10 minutes to deactivate the enzymes. The cDNA was amplified by polymerase chain reaction. Each sample was measured for COX-1, COX-2 and GAPDH cDNA in separate tubes using specific primers. The upstream and downstream primers for COX 1 were 5'-CTGCAT-GTGGCTGTGGATGTCATC-3' and 5 '-AGGACCCGTCATC-TCCAGGGTAATC-3', respectively. These yielded a single band corresponding to a 441 base pair fragment. The sequence for the 441 bp fragment was analyzed by Margaret Robinson in Dr. Ray White's laboratory at the University of Utah using cycle sequencing with fluoresceinated primer ends. Analysis of the sequence revealed that it was identical to position 1374-1815 in mouse COX-1 cDNA [25] . The upstream and downstream COX-1 primers have 46% and 25% homology with mouse COX-2 cDNA [25, 26] . PCR of rat genomic DNA with the primers for COX-1 yielded a single product of about 2 kB, indicating that this primer set spans an intron. The upstream and downstream primers for COX-2 were 5'-CAAGCAGTGGCAAAGGCCTCCATT-3' and 5'-TAGTCT'GGAGTGGGAGGCACTTGC-3', respectively, which yielded a single band corresponding to a 473 base pair cDNA fragment. Analysis of the sequence using cycle sequencing revealed that it was identical to position 1415-1888 in mouse COX-2 cDNA [261. The upstream and downstream COX-2 primers have 46% and 0% homology with mouse COX-1 cDNA [25, 26] . PCR of rat genomic DNA with the primers for COX-2 yielded a single product of about 850 bp, indicating that this primer set spans an intron. The upstream and downstream GAPDH primers were 5'-GTGAAGGTCGGTGTCAACGGATFT-3' and 5 '-CACAG-TCTTCTGAGTGGCAGTGAT-3', respectively, which yielded a single band corresponding to a 558 base pair cDNA fragment. Analysis of the sequence using cycle sequencing revealed that it was identical to position 3-561 in rat GAPDH eDNA [27] . PCR was performed by incubating sample eDNA with 50 mrvt KC1, 10 mM Tris-Cl, 0.01% gelatin, 1.5 mM MgCI2, 2.5% formamide, 2 U Taq polymerase, 200 jiM dNTP, 100 pmoles of primers, and 0.15 jiCi 32P-dCTP in 50 pi final volume (final pH 8.3 at room temperature). PCR using GAPDH primers was carried out for 30 cycles (20 seconds at 94°C, 20 seconds at 65°C, 45 seconds at 72°C) using a Perkin-Elmer Cetus 9600 Gene-Amp System. PCR using COX-1 or COX-2 primers was carried out for 30 cycles under identical conditions. COX-1, COX-2 or GAPDH primers were never combined in the same tube. Twenty jil of the final PCR reaction was electrophoresed using an 8% acrylamide gel in lx Tris-borate-EDTA buffer. Gels were stained with 1 jig/ml ethidium bromide, the bands corresponding to the eDNA product excised, mixed with scintillation cocktail, and cpm determined on a Beckmann beta counter.
COX-1, COX-2 and GAPDH eDNA obtained from PCR of reverse transcribed RNA were used to generate standard curves,
The eDNA was amplified by PCR, the resultant amplified product divided into small fractions that were, in turn, re-amplified. The purity of the final product was confirmed by electrophoresis. If a single band of the appropriate size was obtained, the final product was cleaned using Magic PCR Prep (Promega, Madison, WI, USA) in order to remove the primers. The cleaned product was again electrophoresed to confirm that it contained only the desired eDNA. If pure, the eDNA was quantitated spectrophotometrically. Standard curves for COX-1, COX-2 and GAPDH were made by simultaneously amplifying sample eDNA and, in separate tubes, standard eDNA (101 to 10-8 ng/tube). Every PCR amplification included a standard curve. All PCR consisted of simultaneous amplification (in separate tubes) of eDNA for COX-1, COX-2 and GAPDH. All results are expressed as fg COX-1 or COX-2 eDNA/pg GAPDH eDNA in order to control for the amount of RNA initially reverse transcribed. The accuracy of this quantitative PCR technique has been previously described [28] . In brief, three separate reverse transcriptions of the same RNA sample, followed by PCR of the resultant eDNA (comparing to the same standard curves), yielded no more than a 5% variation in measured sample eDNA; the ratio of COX-1 or COX-2 to GAPDH varied by not more than 6%. In the second control, the reproducibility of quantitation of eDNA was evaluated. Three separate PCR amplifications, each using independently made standard curves, were performed on the same sample of eDNA. The calculated amount of COX-1, COX-2 or GAPDH eDNA varied by no more than 16%, while the ratio of ET-1 to B-actin eDNA varied by 11%. Standard curves using 0.1 to 100 pg of GAPDH eDNA (which encompasses all sample values) gave correlation coefficients invariably greater than 0.98. Similarly, standard curves using 0.1 to 100 fg of COX-1 or COX-2 (which encompasses all sample values) gave correlation coefficients invariably greater than 0,98.
Statistical analysis
All data were analyzed by analysis of variance. Statistical significance was taken as P < 0.05. Values are presented as mean standard error of the mean.
Results
Since basal and agonist-stimulated cyclooxygenase activity in cultured rat mesangial cells may be affected by the growth state of the cells [21], the effect of ET-1 on randomly cycling and growth-arrested cells was assessed first. As shown in Figure 1 , ET-1 greatly enhanced PGE2 release by both cycling and growtharrested cells. As has been previously reported for other agonists, the magnitude of ET-1 stimulation of PGE2 release was greater in cycling than in growth-arrested mesangial cells [21] . Regardless of the growth state of the cells, ET-1 increased PGE2 release after only 15 minutes of exposure and continued to stimulate PGE2 production even after six hours of exposure to the peptide. Hence, it appears that, at least qualitatively, ET-1 stimulation of mesangial cell PGE2 release does not depend on the growth state of the cells. Further, these studies indicate that ET-l causes a prolonged increase in PGE2 release by rat mesangial cells. Lastly, it should be noted that we often observed a large variability in the magnitude of both basal and ET-1-stimulated PGE2 accumulation at the various time points studied, although ET-1 always had a marked stimulatory effect. These differences were manifest not only between cells at different passage numbers, but also between Time, hours plates of cells from the same passage number. The reasons for this variability are unknown; however, we have noticed that slight physical perturbation of cultured cells can release PGE2 (unpublished observations). Consequently, all data in this study were analyzed by comparing controls and treated cells within the same multiwell plate.
The finding that ET-1 increased POE2 release at both early (15 mm) and late (1 to 6 hr) time points raised the question whether the same receptor was mediating these effects. As shown in Figure  2 by growth-arrested mesangial cells was similar at 15 minutes and 6 hours, indicating that similar kinetics exist for both early and late stimulation of PGE2 production by ET-1. The same findings were observed when identical dose-response curves were performed in cycling cells (data not shown). In both growth-arrested and cycling mesangial cells the maximal stimulation of PGE2 release occurred at an ET-1 concentration of 10 nM. Lastly, ET-1 stimulation of PGE2 release was completely blocked at both 15 minutes and 6 hours by 1 M BQ123, a specific antagonist of ET-1 binding to the endothelin A receptor (Fig. 3) [22]. These data indicate, therefore, that ET-1 elicits both rapid and prolonged increases in PGE2 accumulation by activation of the endothelin A receptor.
ET-1 could be stimulating prolonged PGE2 release by a number of mechanisms. To see if increased arachidonic acid release was the sole mechanism of ET-1-stimulated PGE2 synthesis, the ability of ET-1 to increase cyclooxygenase activity was assessed.
Under basal conditions, PGE2 synthesis was maximal in the presence of 10 jIM arachidonic acid, and hence this concentration of arachidonic acid was used for all studies. As shown in Figure 4 , one to six hours of exposure to ET-1 significantly increased mesangial cell PGE2 production in the presence of saturating concentrations of arachidonic acid. These studies indicate, therefore, that prolonged ET-1 stimulation of PGE2 production is due, at least in part, to increases in cyclooxygenase activity. It should be noted that 15 minutes of exposure to ET-1 increased PGE2 release by mesangial cells, but did not alter cyclooxygenase activity (Fig. 4 ). This suggests that the rapid increase in PGE2 release induced by ET-1 is due primarily to increased arachidonic acid availability.
Since the above studies indicated that ET-1 could alter cyclooxygenase activity, we examined the effect of ET-1 on COX-1 and COX-2 protein and mRNA levels. As illustrated in Figure 5 , incubation with ET-1 for six hours had no effect on COX-1 protein levels in mesangial cells. Similarly, incubation with ET-1 for up to six hours had no effect on COX-1 mRNA levels (Fig. 6) . In contrast, incubation with ET-1 for six hours greatly enhanced COX-2 protein levels in mesangial cells (Fig. 5 ), while incubation with ET-1 for one and six hours greatly enhanced COX-2 mRNA levels in mesangial cells (Fig. 6 ). As expected, no change in COX-2 mRNA was seen after only 15 minutes of exposure to These studies indicate that ET-1 causes a selective increase in COX-2 protein and mRNA and that this effect occurs as soon as one hour, and continues for at least six hours, after exposure to ET-1. It should be pointed out, however, that it is not possible to rule out an increase in COX-1 activity that is unassociated with increased COX-1 protein levels.
In order to further confirm that ET-1 stimulation of PGE2 release was dependent, at least in part, on new RNA and protein synthesis, the effects of actinomycin-D and cycloheximide on ET-1 action were examined. As expected, actinomycin-D or cycloheximide had no effect on mesangial cell PGE2 release after only 15 minutes exposure to ET-1 (Panel A in both Figs. 7 and 8) , but significantly reduced the response to six hours of exposure to ET-1. Cycloheximide caused a seven-to eight-fold increase in basal COX-2, but not COX-1, mRNA levels ( Fig. 9 ). There was a massive induction of COX-2 mRNA when mesangial cells were incubated with cycloheximide and ET-1 for six hours; again, COX-1 mRNA levels did not change. Finally, it should be noted that neither actinomycin-D nor cycloheximide completely inhibited ET-1 stimulation of PGE2 production, suggesting that the prolonged stimulation of PGE2 synthesis by ET-1 is due in part to increased protein synthesis and in part to activation of mechanisms which are not dependent upon new protein synthesis.
The effect of dexamethasone on ET-1-stimulated PGE2 production and cyclooxygenase subtype mRNA levels was determined since dexamethasone has been shown to inhibit prostaglandin synthesis in several cell types [17] . Dexamethasone had no effect on total cell protein or cell number. As illustrated in Figure  10 , dexamethasone significantly reduced basal and ET-1-stimulated PGE2 release. This inhibition of ET-1-induced PGE2 synthesis was, however, only partial; PGE2 release still remained significantly above basal levels. The effect of dexamethasone on cyclooxygenase protein and mRNA levels was also assessed. As shown in Figure 5 Fig. 5 . Effect of ET-1 and dexamethasone on cyclooxygenase-1 (COX-1) and -2 (COX-2) protein levels in growth-arrested rat mesangial cells. Cells were pre-incubated with media alone or 2 /.LM dexamethasone for 2 hr, then 10 nM ET-1 was added to half the wells for 6 hr followed by determination of cyclooxygenase protein content by Western analysis. Lanes are as follows: 1-2 = basal; 3-4 = ET-1; 5-6 = dexamethasone; 7-9 = ET-1 + dexamethasone. ET-1). Similarly, dexamethasone lowered ET-1-stimulated COX-2, but not COX-1, mRNA levels in mesangial cells (6 hr exposure to ET-1; Fig. 11 ). As for PGE2 production, the inhibition of COX-2 protein and mRNA levels was not complete. Hence, dexamethasone inhibition of ET-1-induced PGE2 accumulation is associated with a decreased COX-2, but not COX-1, protein and mRNA levels.
Discussion
The current study demonstrates that ET-1 induces both rapid and sustained elevations in rat mesangial cell PGE2 production. Both the rapid and sustained responses to ET-1 are mediated by activation of the endothelin A receptor subtype, have a similar dose-response, and are independent of the growth state of the cells.
ET-1 appears to stimulate mesangial cell PGE2 production by at least two mechanisms. The first involves increasing the availability of arachidonic acid for conversion to PGE2. The rapid effect of ET-1 on mesangial cell free arachidonic acid levels is well characterized. Previous studies have shown that arachidonate release increases within five minutes of exposure of mesangial cells to ET-1 [8] and that ET-1 induces rapid increases in both Ballermann reported that mesangial cells increased PGE2 production in an ET-1-dependent manner when co-incubated with endothelial cells for up to 24 hours, but that excess arachidonate abolished the ability of co-culture to augment PGE2 synthetic rates [13] . Our finding that inhibition of ET-1-induced increases in cyclooxygenase gene transcription (with actinomycin-D) or translation (with cycloheximide) did not completely abolish ET-1stimulated PGE2 production suggests that the ET-1 effect can occur, at least in part, independent of increases in protein synthesis. The second mechanism by which ET-1 stimulates mesangial cell POE2 production involves increased cyclooxygenase activity. We observed that cyclooxygenase activity was increased after one hour, and lasted for at least six hours, of exposure to ET-1. In addition, both actinomycin-D and cycloheximide reduced the stimulatory effect of ET-1 on PGE2 production, supporting a role for new protein synthesis. As discussed earlier, two isoforms of cyclooxygenase have been identified, COX-1 and COX-2. Until recently, only COX-1 was characterized; this enzyme was known to be constitutively expressed by mesangial cells and to be only modestly induced by a variety of cytokines [17] . The discovery of COX-2 generated a great deal of interest since this enzyme was shown to be an early response gene and to be capable of being induced to very high levels of expression [18, 19] . Indeed, the first description of COX-2 expression by mesangial cells was very recently published in which interleukin-1 was shown to stimulate seven-to eight-fold increases in rat mesangial cell COX-2 expression [29] . We undertook, therefore, to determine the effect of ET-1 on COX-1 and COX-2 gene expression. ET-1 caused a marked increase in COX-2 protein and mRNA levels that was present after at least six hours of exposure to the peptide. In contrast, ET-1 had no effect on COX-1 protein or mRNA levels. Interestingly, cycloheximide caused a marked increase in basal and ET-1-stimulated COX-2, but not COX-1, mRNA levels, consistent with previous reports of "superinduction" of COX-2 mRNA in mouse fibroblasts [26] and in human endothelial cells [18] . Taken together, the demonstration of increased cyclooxygenase enzyme activity and increased COX-2 protein and mRNA levels provides strong evidence that ET-1 induction of COX-2 is responsible, at least in part, for prolonged stimulation of mesangial cell PGE2 production. It should be noted that these results contrast with a previous study which found that exposure of quiescent mesangial cells to 100 nM ET-1 for six hours increased cyclooxygenase mRNA, but not activity [21] . This previous study did not measure PGE2 production after six hours of exposure to ET-1, so it is not possible to make direct comparisons. In addition, the previous study did not discriminate between COX-1 and COX-2 mRNA since COX-2 had not been characterized at that time. As discussed above, another group reported that ET-1 increased mesangial cell PGE2 production for up to 24 hours, but failed to detect a change in cyclooxygenase activity [13] . That study is also not strictly comparable with ours since we examined the effect of ET-1 for up to six hours, but not to 24 hours. It is possible, therefore, that ET-1 induction of cyclooxygenase activity is reduced at later time points. This is an area for further investigation.
As mentioned earlier, dexamethasone inhibits prostaglandin synthesis in several cell types [171. Recent studies have suggested that this effect of dexamethasone is mediated primarily by inhibition of COX-2, but not COX-1, synthase activity. For example, dexamethasone inhibited lipopolysaccharide-stimulated COX-2 expression in rat alveolar macrophages and in Swiss 3T3 cells, but had no effect on COX-1 [30, 31] . In agreement with these observations, we found that dexamethasone reduced ET-1 stimulated PGE2 production and that this effect was associated with a reduction in COX-2, but not COX-1, protein and mRNA levels.
This result contrasts with the study by Simonson and colleagues in which dexamethasone was found to have no effect on cyclooxygenase mRNA levels in quiescent mesangial cells [21] . However, for the same reasons mentioned above (PGE2 production and COX-2 levels not measured), comparison between studies is difficult. We also observed that dexamethasone reduced baseline PGE2 production by mesangial cells without associated changes in COX-2 or COX-1 protein or mRNA levels. Dexamethasone has been reported to inhibit cytokine-induced phospholipase A2 activity in cycling mesangial cells [32, 33] ; however its effects on basal arachidonate release are not well studied. This also represents an area for further investigation. Finally, it is highly unlikely that, during the time course studied, the inhibitory effect of dexamethasone on ET-1-stimulated PGE2 accumulation was due to downregulation of ET receptors. Two studies have demonstrated that dexamethasone decreases ET receptor number on endothelial [34] and vascular smooth muscle cells [35] . Both studies, however, failed to detect a significant decrease in ET-1 binding for up to six hours of exposure to the steroid and only a very slight (15%) decrease after eight to nine hours. In contrast, we observed a marked reduction in ET-1 stimulated PGE2 accumulation after only three hours of incubation with dexamethasone. Additionally, after eight hours of dexamethasone exposure, ET-1-stimulated PGE2 accumulation was reduced by 85%, much greater than could be accounted for by even a 15% decrease in ET-1 binding. In summary, the finding that ET-1 induces COX-2 gene expression and prolonged PGE2 synthesis in mesangial cells provides a mechanism for long-term negative feedback regulation of ET-1 action. Further studies are needed to define the role of this inducible form of cyclooxygenase in modifying the renal response to ET-1 and other cytokines.
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